NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000010572

Registered date:30/04/2013

Clinical evaluation of matrix metalloproteinases as early diagnostic markers of peritoneal deterioration and encapsulating peritoneal sclerosis.

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedencapsulating peritoneal sclerosis (EPS)/ sclerosing encapsulating peritonitis(SEP)
Date of first enrollment2004/07/01
Target sample size400
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeClinical evaluation of matrix metalloproteinase level in drained dialysate, mesothelial cell area or others in encapsulating peritoneal sclerosis patients.
Secondary OutcomeClinical evaluation of correlation between peritoneal function and matrix metalloproteinase level in drained dialysate, mesothelial cell area or others in PD patients.

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteriapatients treated with peritoneal dialysis.
Exclude criteriapatients infected with pathogenic organism or virus.

Related Information

Contact

public contact
Name
Address 3311-1 Yakushiji, Shimotsuke-city, Tochigi, 329-0498, Japan Japan
Telephone
E-mail
Affiliation Jichi Medical University Division of Nephrology, Department of Medicine
scientific contact
Name Eiji Kusano
Address 3311-1 Yakushiji, Shimotsuke-city, Tochigi, 329-0498, Japan Japan
Telephone 0285-58-7346
E-mail
Affiliation Jichi Medical University Division of Nephrology, Department of Medicine